Development and characterization of biogenic copper oxide nanoparticles, with an exploration of their antibacterial and antioxidant potential.

This study outlines the synthesis of biogenic copper oxide nanoparticles (CuONPs) using an extract derived from Cassia fistula Linn (Cf) leaves through a green synthesis approach. Characterization of the synthesized CfBio-CuONPs was carried out using UV- VIS, FTIR, DLS, XRD, and TEM studies. The CfBio-CuONPs exhibited a prominent peak at 272 nm in UV-VIS spectroscopy, and XRD measurements confirmed their crystalline nature. The FTIR spectrum of CfBio-CuONPs revealed the presence of functional groups such as O-H and aromatic groups. TEM analysis confirmed that the CfBio-CuONPs were predominantly spherical with diameters ranging from 15 to 25 nm. Subsequently, the antibacterial potential of CfBio-CuONPs was evaluated against four pathogenic bacteria, including Escherichia coli, Pseudomonas aeruginosa, Staphylococcus epidermidis, and Bacillus subtilis. Among these, B. subtilis exhibited the highest zone of inhibition (26.93 ± 2.01 mm), followed by E. coli (24.25 ± 1.04 mm), P. aeruginosa (23.98 ± 0.97 mm), and S. epidermidis (22.97 ± 1.20 mm). CfBio-CuONPs demonstrated maximum antioxidant activity (78 ± 1.54%) at a dose-dependent concentration of 2000 µg/ml. Furthermore, in vitro toxicity assessment using the toxtrak test indicated that CfBio-CuONPs exhibited a significantly stronger toxic effect value/PI against E. coli (93.52%) compared to P. aeruginosa (92.65%), B. subtilis (91.25%), and S. epidermidis (82.89%). These results underscore the notable toxicity of CfBio-CuONPs against E. coli, surpassing that against other bacteria and conventional antibiotics. This study highlights the potential utility of CfBio-CuONPs for eradicating pathogenic microorganisms and suggests potential implications for ecotoxicology. Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-023-03869-5.

Potential of Pueraria tuberosa (Willd.) DC. to rescue cognitive decline associated with BACE1 protein of Alzheimer's disease on Drosophila model: An integrated molecular modeling and in vivo approach.

The indispensable role of Beta-site amyloid precursor protein cleaving enzyme-1 (BACE1) in Amyloid beta (Aß) plaques generation and Aß-mediated synaptic dysfunctions makes it a crucial target for therapeutic intervention in Alzheimer's disease (AD). In order to find out the potential inhibitors of BACE1, the present study focused on five phytochemicals from Pueraria tuberosa, namely, daidzin, genistin, mangiferin, puerarin, and tuberosin. A molecular docking study showed that all five phytochemicals presented the strongest BACE1 inhibition. Integrated molecular dynamics simulations and free energy calculations demonstrated that all five natural compounds have stable and favorable energies causing strong binding with the pocket site of BACE1 on 50 ns. All these molecules also passed Lipinski's rule of five. To validate the molecular modeling based findings, we primarily targeted the cognitive decline associated with BACE1 expression in AD flies with P. tuberosa. Significant improvement in cognitive decline was observed in AD flies in different behavioral assays such as Larval crawling assay (16.38%), Larval light preference assay (26.39%), Climbing assay (32.97%), Cold sensitivity assay (43.6%), and Thermal sensitivity assay (44.42%). The present findings suggest that P. tuberosa may be considered as a promising dietary supplement that can significantly ameliorate cognitive decline caused by BACE1 in Alzheimer's disease (AD).

Correction: Synthesis of non-toxic, biocompatible, and colloidal stable silver nanoparticle using egg-white protein as capping and reducing agents for sustainable antibacterial application.

[This corrects the article DOI: 10.1039/C8RA03649G.].

Synthesis of non-toxic, biocompatible, and colloidal stable silver nanoparticle using egg-white protein as capping and reducing agents for sustainable antibacterial application.

For nearly a decade, silver nanoparticles (AgNPs) have been the most prevalent commercial nanomaterials products widely used in different biomedical applications due to their broad-spectrum antimicrobial activity. However, their poor long-term stability in different environments, namely, pH, ionic strength, and temperature, and cytotoxicity toward mammalian cells has restricted their more extensive applications. Hence, there is urgent need to develop highly biocompatible, non-toxic, and stable silver nanoparticles for wide-ranging environments and applications. In the present study, a simple, sustainable, cost-effective and green method has been developed to prepare highly stable aqueous colloidal silver nanoparticles (AgNPs-EW) using the ovalbumin, ovotransferrin, and ovomucoid of egg-white as reducing and capping agents accomplished under the irradiation of direct sunlight. Then, we evaluated the effects of freezing-drying (lyophilization) and freeze-thaw cycles on the stability of AgNPs-EW in aqueous solution under visual inspection, transmission electron microscopy, and absorbance spectroscopy. In addition, we studied the antibacterial activity against Salmonella typhimurium and Escherichia coli, carried out biocompatibility studies on chicken blood, and tested acute, chronic toxicity in Drosophila melanogaster. The results suggest that AgNPs-EW did not aggregate upon freeze-thawing and lyophilization, thus exhibiting remarkable stability. The antibacterial activity results showed that the AgNPs-EW had the highest antibacterial activity, and the minimum inhibitory concentration (MIC) of AgNPs-EW for E. Coli and S. typhimurium were 4 and 6 µg ml-1, respectively. The biocompatibility study revealed that the AgNPs-EW did not induce any hemolytic effect or structural damage to the cell membranes of chicken erythrocytes up to a concentration of 12 µg ml-1. Similarly, no acute and chronic toxicity was observed on melanization, fecundity, hatchability, viability, and the duration of development in the 1st generation of Drosophila melanogaster at the concentration range of 10 mg L-1 to 100 mg L-1 of AgNPs-EW, and all the flies completed their full developmental cycle. Therefore, the present study successfully demonstrated the green and sustainable preparation of non-toxic AgNPs-EW having good biocompatibility, enhanced colloidal stability, and antibacterial activity. Hence, the synthesized AgNPs-EW could be used for the development of an antimicrobial formulation for controlling microbial infection.